Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Washington Drug Letter > Canadian Drugmaker Warned for Vendor Qualification Lapses

Washington Drug Letter

Nov. 12, 2012 | Vol. 44 No. 45

Canadian Drugmaker Warned for Vendor Qualification Lapses

The FDA has hit International Laboratories Canada with a warning letter for good manufacturing practice (GMP) violations related to supplier qualification and the company’s quality control unit.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Related Articles

DOJ Submits 11th-Hour Appeal of N.Y. Judge’s Plan B Ruling FDA Warning Letter(s)DOJ’s Plan B Stay Request Denied; Judge Sets Monday Noon Deadline Objection, Your Honor: DOJ Appeals Plan B Court Order

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.